Research ExplorerPublicationsReduced treatment intensity in patients with early-stage Hod...

Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

Standard

Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. / Engert, Andreas; Plütschow, Annette; Eich, Hans Theodor; Lohri, Andreas; Dörken, Bernd; Borchmann, Peter; Berger, Bernhard; Greil, Richard; Willborn, Kay C; Wilhelm, Martin; Debus, Jürgen; Eble, Michael J; Sökler, Martin; Ho, Antony; Rank, Andreas; Ganser, Arnold; Trümper, Lorenz; Bokemeyer, Carsten; Kirchner, Hartmut; Schubert, Jörg; Král, Zdenek; Fuchs, Michael; Müller-Hermelink, Hans-Konrad; Müller, Rolf-Peter; Diehl, Volker.

In: NEW ENGL J MED, Vol. 363, No. 7, 7, 2010, p. 640-652.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Engert, A, Plütschow, A, Eich, HT, Lohri, A, Dörken, B, Borchmann, P, Berger, B, Greil, R, Willborn, KC, Wilhelm, M, Debus, J, Eble, MJ, Sökler, M, Ho, A, Rank, A, Ganser, A, Trümper, L, Bokemeyer, C, Kirchner, H, Schubert, J, Král, Z, Fuchs, M, Müller-Hermelink, H-K, Müller, R-P & Diehl, V 2010, 'Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.', NEW ENGL J MED, vol. 363, no. 7, 7, pp. 640-652. <http://www.ncbi.nlm.nih.gov/pubmed/20818855?dopt=Citation>

APA

Engert, A., Plütschow, A., Eich, H. T., Lohri, A., Dörken, B., Borchmann, P., Berger, B., Greil, R., Willborn, K. C., Wilhelm, M., Debus, J., Eble, M. J., Sökler, M., Ho, A., Rank, A., Ganser, A., Trümper, L., Bokemeyer, C., Kirchner, H., ... Diehl, V. (2010). Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. NEW ENGL J MED, 363(7), 640-652. [7]. http://www.ncbi.nlm.nih.gov/pubmed/20818855?dopt=Citation

Vancouver

Engert A, Plütschow A, Eich HT, Lohri A, Dörken B, Borchmann P et al. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. NEW ENGL J MED. 2010;363(7):640-652. 7.

Bibtex

@article{ef4be355faf145ddb0e3a0f035b39a52,
title = "Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.",
abstract = "Whether it is possible to reduce the intensity of treatment in early (stage I or II) Hodgkin's lymphoma with a favorable prognosis remains unclear. We therefore conducted a multicenter, randomized trial comparing four treatment groups consisting of a combination chemotherapy regimen of two different intensities followed by involved-field radiation therapy at two different dose levels.",
author = "Andreas Engert and Annette Pl{\"u}tschow and Eich, {Hans Theodor} and Andreas Lohri and Bernd D{\"o}rken and Peter Borchmann and Bernhard Berger and Richard Greil and Willborn, {Kay C} and Martin Wilhelm and J{\"u}rgen Debus and Eble, {Michael J} and Martin S{\"o}kler and Antony Ho and Andreas Rank and Arnold Ganser and Lorenz Tr{\"u}mper and Carsten Bokemeyer and Hartmut Kirchner and J{\"o}rg Schubert and Zdenek Kr{\'a}l and Michael Fuchs and Hans-Konrad M{\"u}ller-Hermelink and Rolf-Peter M{\"u}ller and Volker Diehl",
year = "2010",
language = "Deutsch",
volume = "363",
pages = "640--652",
journal = "NEW ENGL J MED",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "7",

}

RIS

TY - JOUR

T1 - Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

AU - Engert, Andreas

AU - Plütschow, Annette

AU - Eich, Hans Theodor

AU - Lohri, Andreas

AU - Dörken, Bernd

AU - Borchmann, Peter

AU - Berger, Bernhard

AU - Greil, Richard

AU - Willborn, Kay C

AU - Wilhelm, Martin

AU - Debus, Jürgen

AU - Eble, Michael J

AU - Sökler, Martin

AU - Ho, Antony

AU - Rank, Andreas

AU - Ganser, Arnold

AU - Trümper, Lorenz

AU - Bokemeyer, Carsten

AU - Kirchner, Hartmut

AU - Schubert, Jörg

AU - Král, Zdenek

AU - Fuchs, Michael

AU - Müller-Hermelink, Hans-Konrad

AU - Müller, Rolf-Peter

AU - Diehl, Volker

PY - 2010

Y1 - 2010

N2 - Whether it is possible to reduce the intensity of treatment in early (stage I or II) Hodgkin's lymphoma with a favorable prognosis remains unclear. We therefore conducted a multicenter, randomized trial comparing four treatment groups consisting of a combination chemotherapy regimen of two different intensities followed by involved-field radiation therapy at two different dose levels.

AB - Whether it is possible to reduce the intensity of treatment in early (stage I or II) Hodgkin's lymphoma with a favorable prognosis remains unclear. We therefore conducted a multicenter, randomized trial comparing four treatment groups consisting of a combination chemotherapy regimen of two different intensities followed by involved-field radiation therapy at two different dose levels.

M3 - SCORING: Zeitschriftenaufsatz

VL - 363

SP - 640

EP - 652

JO - NEW ENGL J MED

JF - NEW ENGL J MED

SN - 0028-4793

IS - 7

M1 - 7

ER -